This bill amends Section 50-32-232 of the Montana Code Annotated (MCA) to revise the list of specific dangerous drugs included in Schedule V of controlled substances. A significant change in the bill is the addition of gabapentin, also known as 1-(aminomethyl)cyclohexaneacetic acid, to the list of depressants. This inclusion is part of a broader effort to regulate substances that have potential for abuse or dependency.

Additionally, the bill removes the reference to pregabalin, also known as (S)-3-(aminomethyl)-5-methylhexanoic acid, from the list of depressants, while maintaining the inclusion of lacosamide and other anticonvulsant substances. The overall aim of the bill is to enhance public health and safety by ensuring that substances with potential for misuse are appropriately classified and regulated.

Statutes affected:
LC Text: 50-32-232
HB0041_1(1): 50-32-232
HB0041_1(2): 50-32-232
HB0041_1(3): 50-32-232
HB0041_1(4): 50-32-232
HB0041_1(5): 50-32-232
HB0041_1(6): 50-32-232
HB0041_1: 50-32-232
HB0041_2(1): 50-32-232
HB0041_2(10): 50-32-232
HB0041_2(11): 50-32-232
HB0041_2(2): 50-32-232
HB0041_2(3): 50-32-232
HB0041_2(4): 50-32-232
HB0041_2(5): 50-32-232
HB0041_2(6): 50-32-232
HB0041_2(7): 50-32-232
HB0041_2(8): 50-32-232
HB0041_2(9): 50-32-232
HB0041_2: 50-32-232
HB0041_X(1): 50-32-232
HB0041_X(2): 50-32-232
HB0041_X(3): 50-32-232
HB0041_X(4): 50-32-232
HB0041_X(5): 50-32-232
HB0041_X(6): 50-32-232
HB0041_X(7): 50-32-232
HB0041_X(8): 50-32-232
HB0041_X: 50-32-232